Traveler Diarrhea
📧 Sign up to get email alerts when something new happens for Traveler Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. [Phase 2]
Phase 2 trial evaluating once-daily IMM-124E (Travelan) for efficacy in a controlled human infection model in travelers with diarrhea condit…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model [Phase 2]
This update reports the completion of a Phase 2 trial evaluating IMM-124E (Travelan) for prevention of traveler’s diarrhea and related infec…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase 2 Bridging Study to Assess the New Formulation of ETVAX [Phase 2]
A Phase 2 bridging study evaluating a new formulation of the ETVAX vaccine has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Prevention of Traveler's Diarrhea [Phase 2]
A Phase 2 clinical trial evaluating prevention of traveler's diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea in children aged 6 to 11.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years [Phase 2]
Phase 2 study evaluating safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea in adolescents aged 12-17 is in progress with unkno…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea [Phase 3]
A Phase 3 trial comparing rifaximin with Xifaxan 200 mg for traveler’s diarrhea has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. [Phase 3]
Phase 3 clinical trial update on prevention of travelers' diarrhea in subjects traveling outside the U.S. completed.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea [Phase 1]
Phase 1 safety study of a chimeric vaccine to prevent ETEC diarrhea has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea [Phase 3]
Phase 3 trial comparing Rifamycin SV-MMX tablets to ciprofloxacin for acute traveler’s diarrhea has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli [NA]
Completed clinical trial evaluating PTM202 for modulation of host resistance to diarrheagenic Escherichia coli in travelers with traveler's …
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) [Phase 3]
Phase 3 study evaluating the safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea has completed and results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17 [Phase 1]
A Phase 1 dose-finding trial evaluated WS6788A and LSN03-016011/A against CS17-expressing enterotoxigenic E. coli strains in a challenge-mod…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea [NA]
An ambulatory-treatment trial for travelers' diarrhea conducted by Uniformed Services University of the Health Sciences has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea [Phase 3]
Phase 3 study evaluating prulifloxacin vs placebo for traveler's diarrhea has completed, reporting on safety and efficacy in adult travelers…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: LT Vaccine Patch Self-Administration Study [Phase 2]
Phase 2 trial update for a self-administered LT vaccine patch in preventing travelers' diarrhea; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch [Phase 2]
Phase 2 safety and immunogenicity study of a Traveler's Diarrhea vaccine patch completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled study evaluating prevention of traveler's diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study [Phase 2]
Phase 2 Asia efficacy study of a Traveler's diarrhea vaccine by Intercell USA, Inc. has completed; this is a status update on the trial.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Probiotics and the Prevention of Traveler's Diarrhea [Phase 4]
Phase 4 clinical trial evaluating a probiotic formulation for prevention of traveler's diarrhea; study terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-21Clinical Trial Update: Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults [Phase 3]
Phase 3 trial evaluating BIO-K+ CL1285 Prophylaxis for preventing traveler's diarrhea in adults has completed; results are not detailed in t…
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea [Phase 4]
Phase 4 clinical trial evaluating rifaximin, loperamide, and their combination for traveler's diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-15Clinical Trial Update: Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I [Phase 1]
Phase 1 trial evaluating the efficacy of anti-CFA/I and CfaE bovine milk immunoglobulin to prevent diarrhea after challenge with CFA/I-expre…
-
CLINICAL_TRIALS trial_result · 2006-05-09Clinical Trial Update: Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea [Phase 2]
Phase 2 trial evaluating rifaximin versus placebo for preventing traveler’s diarrhea has completed.